Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Danny A Zwijnenburg
Affiliation
ORCID
Career Start Year
1998
Papers
28
H Index
19
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37646174
Iron-responsive element of Divalent metal transporter 1 (Dmt1) controls Notch-mediated cell fates.
FEBS J
2023
34853072
Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors.
Cancer Res
2022
35844173
Correction: Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors.
Cancer Res
2022
36334593
Estrogen-related receptor alpha drives mitochondrial biogenesis and resistance to neoadjuvant chemoradiation in esophageal cancer.
Cell Rep Med
2022
35400598
A Common Genomic Denominator for Neuroblastoma and Differentiated Thyroid Carcinoma? A Case Series in Children.
Clin Oncol (R Coll Radiol)
2022
34479993
Defects in 8-oxo-guanine repair pathway cause high frequency of C > A substitutions in neuroblastoma.
Proc Natl Acad Sci U S A
2021
33466359
Specific and Sensitive Detection of Neuroblastoma mRNA Markers by Multiplex RT-qPCR.
Cancers (Basel)
2021
30948783
A NOTCH feed-forward loop drives reprogramming from adrenergic to mesenchymal state in neuroblastoma.
Nat Commun
2019
31802000
The molecular landscape of ETMR at diagnosis and relapse.
Nature
2019
29731961
Macrophages induce "budding" in aggressive human colon cancer subtypes by protease-mediated disruption of tight junctions.
Oncotarget
2018
30115695
RAS-MAPK Pathway-Driven Tumor Progression Is Associated with Loss of CIC and Other Genomic Aberrations in Neuroblastoma.
Cancer Res
2018
29489754
The landscape of genomic alterations across childhood cancers.
Nature
2018
28650485
Neuroblastoma is composed of two super-enhancer-associated differentiation states.
Nat Genet
2017
26996663
Collagen-rich stroma in aggressive colon tumors induces mesenchymal gene expression and tumor cell invasion.
Oncogene
2016
26121087
Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations.
Nat Genet
2015
25445214
Whole-genome sequencing identifies patient-specific DNA minimal residual disease markers in neuroblastoma.
J Mol Diagn
2015
26523776
TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors.
Nat Genet
2015
24321263
Newly-derived neuroblastoma cell lines propagated in serum-free media recapitulate the genotype and phenotype of primary neuroblastoma tumours.
Eur J Cancer
2014
23179372
OTX2 sustains a bivalent-like state of OTX2-bound promoters in medulloblastoma by maintaining their H3K27me3 levels.
Acta Neuropathol
2013
21964830
OTX2 directly activates cell cycle genes and inhibits differentiation in medulloblastoma cells.
Int J Cancer
2012
22367537
Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes.
Nature
2012
22016811
Joint binding of OTX2 and MYC in promotor regions is associated with high gene expression in medulloblastoma.
PLoS One
2011
20068162
Silencing of SPRY1 triggers complete regression of rhabdomyosarcoma tumors carrying a mutated RAS gene.
Cancer Res
2010
21047732
Regulation of cell cycle genes and induction of senescence by overexpression of OTX2 in medulloblastoma cell lines.
Mol Cancer Res
2010
15629888
Full transcriptome analysis of rhabdomyosarcoma, normal, and fetal skeletal muscle: statistical comparison of multiple SAGE libraries.
FASEB J
2005
15955238
Evaluation of the similarity of gene expression data estimated with SAGE and Affymetrix GeneChips.
BMC Genomics
2005
12060695
Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification.
Nucleic Acids Research
2002
9421501
The C-terminal region of the Escherichia coli UvrC protein, which is homologous to the C-terminal region of the human ERCC1 protein, is involved in DNA binding and 5'-incision.
Nucleic Acids Research
1998
1 - 28 of 28
Column Actions
Search
Recommended Authors
Collaborators
Jan Koster
Amsterdam University Medical Centers location AMC
Co-authored papers
21
Jan J Molenaar
Co-authored papers
10
Marcel Kool
Hopp Children's Cancer Center (KiTZ)
Co-authored papers
9
C Ellen van der Schoot
Co-authored papers
3
Piet Molenaar
Academic Medical Center
Co-authored papers
3
Jan Paul Medema
Oncode Institute
Co-authored papers
2
Peter Lichter
German Cancer Research Center (DKFZ)
Co-authored papers
2
Susanne Gr??bner
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers
2
Ivo Buchhalter
German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Co-authored papers
2
Stephan Wolf
Co-authored papers
2
Sebastian M Waszak
University of California san francisco
Co-authored papers
2
Jan O Korbel
European Bioinformatics Institute (EMBL-EBI)
Co-authored papers
2
David T W Jones
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers
2
Olaf Witt
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers
2
Sander Lambo
Co-authored papers
2
Johannes H Schulte
Co-authored papers
2
Stefan M Pfister
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers
2
Katja von Hoff
Co-authored papers
2
Sebastian Brabetz
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers
2
Pablo Landgraf
Co-authored papers
2
Matthias Schlesner
University of Augsburg
Co-authored papers
1
Thomas Klingebiel
Co-authored papers
1
Joachim Weischenfeldt
University of Copenhagen
Co-authored papers
1
Gilles Vassal
Co-authored papers
1
Franck Bourdeaut
SIREDO Oncology Center, Institut Curie Hospital, and Universite de Paris
Co-authored papers
1
Jenny Wegert
Co-authored papers
1
Udo Kontny
Co-authored papers
1
Stefan Burdach
Technische Universitat Munchen
Co-authored papers
1
Simone Hettmer
University Medical Center Freiburg, University of Freiburg
Co-authored papers
1
Frank Westermann
Co-authored papers
1
1 - 30